Solute Carrier Family 19,Member 1 ( SLC19A1 ) Polymorphisms (−43T>C,80G>A,and 696C>T),and Haplotypes in Idiopathic Recurrent Spontaneous Abortion in a Korean Population
Restricted accessResearch articleFirst published online May, 2012
Solute Carrier Family 19,Member 1 ( SLC19A1 ) Polymorphisms (−43T>C,80G>A,and 696C>T),and Haplotypes in Idiopathic Recurrent Spontaneous Abortion in a Korean Population
The objective was to investigate the association between idiopathic recurrent spontaneous abortion (RSA) and 3 SLC19A1 polymorphisms (−43T>C, 80G>A, and 696C>T). DNA from 269 patients with RSA and 125 controls were genotyped for the 3 SLC19A1 single nucleotide polymorphisms (SNPs) by polymerase chain reaction–restriction fragment length polymorphism. Homocysteine and folate levels of 100 patients with RSA were available for analysis. The combination genotypes of SLC19A1 −43TC/80GG, −43TC/80AA, and −43CC/80GA; 80GA/696TT, 80AA/696CC; and −43TC/696CC were less frequent in patients with RSA compared to controls (P < .05 for each). The −43C/80A/696 T and −43T/80G/696C haplotypes were more frequent in patients than controls, whereas −43T/80A/696C, −43C/80A/696C, −43C/80G/696C, −43C/80G/696T, and −43T/80G/696T haplotypes were less frequent in patients (P < .05 for each). The −43T/80G and 80A/696T haplotypes were more frequent in patients, while −43T/80A, −43C/80G, 80A/696C, 80G/696T, and −43C/696C haplotypes occurred less frequently in patients (P < .05 for each). The associations between idiopathic RSA occurrence and SLC19A1 −43T>C/80G>A/696C>T polymorphisms were identified and can be developed as biomarkers for RSA risk.
CliffordKRaiRWatsonHReganL. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod. 1994;9(7):1328–1332.
3.
Steegers-TheunissenRPBoersGHTrijbelsFJ. Maternal hyper-homocysteinemia: a risk factor for neural-tube defects?Metabolism. 1994;43(12):1475–1480.
4.
DekkerGAde VriesJIDoelitzschPM. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol. 1995;173(4):1042–1048.
5.
Goddijn-WesselTAWoutersMGvan de MolenEF. Hyperhomocysteinemia: a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol. 1996;66(1):23–29.
6.
WoutersMGBoersGHBlomHJ. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril. 1993;60(5):820–825.
7.
MillerJWNadeauMRSmithDSelhubJ. Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats. Am J Clin Nutr. 1994;59(5):1033–1039.
8.
van GuldenerCStehouwerCD. Homocysteine-lowering treatment: an overview. Expert Opin Pharmacother. 2001;2(9):1449–1460.
9.
FrosstPBlomHJMilosR. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111–113.
10.
WeisbergITranPChristensenBSibaniSRozenR. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64(3):169–172.
11.
MillsJLMcPartlinJMKirkePN. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 1995;345(8943):149–151.
12.
AltmaeSStavreus-EversARuizJR. Variations in folate pathway genes are associated with unexplained female infertility. Fertil Steril. 2010;94(1):130–137.
13.
NelenWLBlomHJThomasCMSteegersEABoersGHEskesTK. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr. 1998;128(8):1336–1341.
14.
TamuraTPiccianoMF. Folate and human reproduction. Am J Clin Nutr. 2006;83(5):993–1016.
15.
TapariaSGelineau-van WaesJRosenquistTHFinnellRH. Importance of folate-homocysteine homeostasis during early embryonic development. Clin Chem Lab Med. 2007;45(12):1717–1727.
16.
GeorgeLMillsJLJohanssonAL. Plasma folate levels and risk of spontaneous abortion. JAMA. 2002;288(15):1867–1873.
17.
MartinRHHarperTAKelsoW. Serum-folic-acid in recurrent abortions. Lancet. 1965;1(7387):670–672.
18.
GeorgeLGranathFJohanssonALOlanderBCnattingiusS. Risks of repeated miscarriage. Paediatr Perinat Epidemiol. 2006;20(2):119–126.
19.
NelenWLBlomHJSteegersEAden HeijerMThomasCMEskesTK. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol. 2000;95(4):519–524.
20.
SutterlinMBussenSRuppertDSteckT. Serum levels of folate and cobalamin in women with recurrent spontaneous abortion. Hum Reprod. 1997;12(10):2292–2296.
21.
PickellLLiDBrownK. Methylenetetrahydrofolate reductase deficiency and low dietary folate increase embryonic delay and placental abnormalities in mice. Birth Defects Res A Clin Mol Teratol. 2009;85(6):531–541.
22.
ChiaoJHRoyKTolnerBYangCHSirotnakFM. RFC-1 gene expression regulates folate absorption in mouse small intestine. J Biol Chem. 1997;272(17):11165–11170.
23.
ChatzikyriakidouAGeorgiouIVoulgariPVPapadopoulosCGTzavarasTDrososAA. Transcription regulatory polymorphism -43T>C in the 5'-flanking region of SLC19A1 gene could affect rheumatoid arthritis patient response to methotrexate therapy. Rheumatol Int. 2007;27(11):1057–1061.
24.
ChangoABoissonFBarbeF. The effect of 677C-->T and 1298A-->C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr. 2000;83(6):593–596.
25.
ReltonCLWildingCSJonasPALynchSATawnEJBurnJ. Genetic susceptibility to neural tube defect pregnancy varies with offspring phenotype. Clin Genet. 2003;64(5):424–428.
26.
De MarcoPCalevoMGMoroniA. Reduced folate carrier polymorphism (80A-->G) and neural tube defects. Eur J Hum Genet. 2003;11(3):245–252.
27.
ChatzikyriakidouAVakalisKVKolaitisN. Distinct association of SLC19A1 polymorphism -43T>C with red cell folate levels and of MTHFR polymorphism 677C>T with plasma folate levels. Clin Biochem. 2008;41(3):174–176.
28.
WhetstineJRGiffordAJWittT. Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers. Clin Cancer Res. 2001;7(11):3416–3422.
29.
HibbardBM. The role of folic acid in pregnancy; with particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Commonw. 1964;71:529–542.
30.
NelenWLSteegersEAEskesTKBlomHJ. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet. 1997;350(9081):861.
31.
Stanislawska-SachadynAMitchellLEWoodsideJV. The reduced folate carrier (SLC19A1) c.80G>A polymorphism is associated with red cell folate concentrations among women. Ann Hum Genet. 2009;73(pt 5):484–491.
32.
ChangoAEmery-FillonNde CourcyGP. A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab. 2000;70(4):310–315.
33.
NelenWLBultenJSteegersEABlomHJHanselaarAGEskesTK. Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss. Hum Reprod. 2000;15(4):954–960.
34.
YatesZLucockM. G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanism. Life Sci. 2005;77(22):2735–2742.
35.
JeonYJChoiYSRahHC. The reduced folate carrier-1 (RFC1 696T>C) polymorphism is associated with spontaneously aborted embryos in Koreans. Genes Genom. 2011;33(3):223–228.
36.
DuanJWainwrightMSComeronJM. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet. 2003;12(3):205–216.
37.
KomarAA. Silent SNPs: impact on gene function and phenotype. Pharmacogenomics. 2007;8(8):1075–1080.
38.
Kimchi-SarfatyCOhJMKimIW. A “silent“ polymorphism in the MDR1 gene changes substrate specificity. Science. 2007;315(5811):525–528.
39.
BartoszewskiRAJablonskyMBartoszewskaS. A synonymous single nucleotide polymorphism in DeltaF508 CFTR alters the secondary structure of the mRNA and the expression of the mutant protein. J Biol Chem. 2010;285(37):28741–28748.
40.
AnanthCVPeltierMRMooreDFKinzlerWLLeclercDRozenRR. Reduced folate carrier 80A-->G polymorphism, plasma folate, and risk of placental abruption. Hum Genet. 2008;124(2):137–145.
41.
BaeJChoiDHKangMSChaSHOhDKimNK. Effect of methylenetetrahydrofolate reductase and thymidylate synthase enhancer region polymorphisms on the risk of idiopathic recurrent spontaneous abortion in a Korean population. Fertil Steril. 2009;91(4 suppl):1560–1562.
42.
RenAWangJ. Methylenetetrahydrofolate reductase C677 T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis. Fertil Steril. 2006;86(6):1716–1722.
